Gynecologic Extramammary Paget's Disease

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT03564483
Status
Recruiting

Conditions

  • Extramammary Paget Disease
  • Extramammary Paget's Disease
  • Extramammary Paget's Disease Vulva Invasive
  • Extramammary Paget's Disease of Anal Canal (Diagnosis)
  • Extramammary Paget's Disease of Anus (Diagnosis)
  • Extramammary Paget's Disease of Skin
  • Extramammary Paget's Disease of Vagina (Diagnosis)
  • Extramammary Paget's Disease of Vulva (Diagnosis)
  • Paget Disease, Extramammary

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.

Key Dates

Start date
Feb 19, 2018
Status verified
Jan 2026
Primary completion
Dec 31, 2050
Completion
Dec 31, 2050

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Registry Observational Study
    All women presenting for evaluation of Extramammary Paget's Disease (EMPD) at Mayo Clinic in Rochester MN.

Primary Outcome Measure

Collect prospective data including outcomes and long-term survival in women with extramammary Paget's disease (EMPD). [ Time Frame: 25 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Maureen A. Lemens, R.N.
507-293-1487
Karen P Ishitani, RN
507-538-5355
Jamie N. Bakkum-Gamez, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

Related Studies